The next couple of months... Strikes me there two interesting developments in the works that should positively affect the SP:
1)Once the December binding letter agreement for the acquisition of Food Labs, Inc. and strategic investor relationship with Toba Capital LLC is finalized (which should be very soon) Food Labs’ Michael Cancelleri will become Chief Executive Officer and Chairman of the Board of Directors of Isodiol. His contacts and proven track record of bringing products quickly to mass market will be a much needed bonus to Isodiol’s marketing efforts as cannabis and hemp-based products become increasingly common on store and pharmacy shelves.
2) Today it was announced Zenabis Global Inc. has entered into a supply agreement with Canada’s Shoppers Drug Mart. They will supply the national chain with dried marijuana and cannabis oil (once Zenabis receives its licence to sell oil) from the Zenabis medical branded product line. Shoppers will also have the right to purchase all future Zenabis branded medical cannabis products available, to be sold online at Cannannabis.shoppersdrugmart.ca, as regulations do not allow the sale of medical cannabis in retail pharmacies.
In May, 2018, Isodiol signed a letter of intent with Zenabis to import CBD isolate as an Active Pharmaceutical Ingredient, into Canada from Isodiol’s GMP-certified production facility in the United Kingdom. And, upon successful initial import and product testing, Zenabis and Isodiol intend to execute a Definitive Supply Agreement, which expects to expand the scope of the collaboration, in addition to the supply of raw isolate.
These two imminent developments lead me to believe the next couple of months will be very “moving” for Isodiol shareholders. (Zenabis Global Inc. stock price rose .46 today.)